The New York-based firm is questioning the valuation and disclosure standards surrounding four specific high-profile deals. CBIZ, Inc. shareholders are looking at a $55.00 cash-per-share sale to Grant Thornton Advisors, while Safety Insurance Group investors are evaluating a $105.00-per-share cash offer from an affiliate of Mapfre S.A.
Concerns extend to equity-based mergers involving Neuphoria Therapeutics and TriCo Bancshares. In the Neuphoria deal with Scancell Holdings, shareholders are slated to retain only 14.5% of the combined entity. Meanwhile, the TriCo Bancshares transaction involves a stock-for-stock exchange with First Hawaiian, Inc., leaving TriCo investors with an expected 35% stake in the successor company. Halper Sadeh attorneys argue that these structures may suppress superior competing offers and are currently seeking increased compensation or enhanced transparency for those impacted.



Comments (0)
No comments yet. Be the first!